Living with Rheumatoid Arthritis (RA) Deb’s Experience with Low Dose Naltrexone (LDN)

Deb from Australia shared her journey with rheumatoid arthritis, which she experienced for about four years before receiving a proper diagnosis. Initially, her GP attributed her chronic pain to other issues and suggested topical treatments. A physio at Nambbor General Hospital recognized her symptoms and referred her to a rheumatologist, who confirmed the diagnosis through […]

Side Effects of Low Dose Naltrexone: What You Should Know (2023)

Side Effects of Low Dose Naltrexone: What You Should Know (Nov 2nd, 2023) By: Louis A. Cona, MD, Da Vinci Wellness Centre https://www.dvcstem.com/post/side-effects-of-low-dose-naltrexone Side Effects of LDN The LDN side effects can vary but generally include symptoms like fatigue, sleep disturbances, and gastrointestinal issues like diarrhea or nausea. According to a study by Dove Press, […]

Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions… (Abstract)

Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions – A Scoping Review Pain Med 11 June 2023 https://pubmed.ncbi.nlm.nih.gov/37302106/ Background: At low doses, naltrexone (LDN) has been shown to modulate inflammation through the interruption of microglial cell activation within the central nervous system. One of the most likely contributors to centralized pain is changes in […]

Opiate Antagonists for Chronic Pain… (Abstract)

Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases Biomedicines 02 June 2023 https://pubmed.ncbi.nlm.nih.gov/37371715/ Chronic pain conditions create major financial and emotional burdens that can be devastating for individuals and society. One primary source of pain is arthritis, a common inflammatory disease of the joints that […]

Low-Dose Naltrexone in Rheumatological Diseases (Abstract)

Low-Dose Naltrexone in Rheumatological Diseases Mediterr J Rheumatol 31 March 2023 https://pubmed.ncbi.nlm.nih.gov/37223594/ Background: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders. Aim: To review the use of LDN in rheumatic diseases: systemic […]

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia… (Abstract)

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis Biomedicines As revised 23 March 2023 https://www.mdpi.com/2227-9059/11/4/1087 Current pharmacologic treatments may provide limited analgesia in fibromyalgia and other chronic pain disorders. Low-dose naltrexone (LDN) has emerged as a potential analgesic option that […]